Klinic prescribes four FDA-approved options: Zepbound (tirzepatide injection, once weekly), Wegovy (semaglutide injection, once weekly), Oral Wegovy (semaglutide tablet, once daily), and Foundayo (orforglipron tablet, once daily)

Findings from Iqbal Study Leila Taj , Institute for Global Health Sciences, San Francisco, CA, United States The Power of Visualizing Global Health: Lessons Learned from Collaborative Filmmaking Projects Implemented Across Nine Countries Sara Baumann , University of Pittsburgh, Pittsburgh, PA, United States Evaluating The Effectiveness of an AI-Based Digital Health Intervention in Improving Maternal Health Outcomes Among Refugees and Underserved Women in Lebanon Nour El Arnaout , American University of Beirut, Beirut, Lebanon Expanding Global Health Innovation Infrastructure through Plastics Recycling for Local Additive Manufacturing in Malawi Ayah Ali , Virginia Tech Blacksburg, VA, United States Shadi Saleh American University of Beirut Andrew Marvin Kanyike University of Exeter Malechi Hawa University for Development Studies, Tamale Teaching Hospital Ghana Odume Bethrand KNCV Nigeria Leila Taj Institute for Global Health Sciences Nour El Arnaout American University of Beirut Ayah Ali Virginia Tech Sara Baumann University of Pittsburgh Moderator: Tracy Rabin Global health education partnerships between academic institutions in the U.S

The post frames this as a reason for closer provider monitoring rather than an automatic barrier to using both treatments together
Longer treatment typically equates to higher overall costs
The prices from the manufacturer are unknown as Zepbound comes off the shortage list, but the cost from the compounding pharmacies should stay relatively stable